Takayasu Arteritis Clinical Trials

61 clinical trials for Takayasu Arteritis across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases — RECRUITING · PHASE4
• EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases — RECRUITING
• Global Initiative on Takayasu Arteritis (GITA) — RECRUITING
• Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission — RECRUITING · NA
• Vasculitis Pregnancy Registry — RECRUITING
• VCRC Tissue Repository — RECRUITING
• Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis — RECRUITING
• Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV) — RECRUITING · PHASE2
• Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls — RECRUITING
• Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases — RECRUITING
• A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis — RECRUITING · PHASE4
• Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis — RECRUITING · PHASE4
• Remote Ischemic Conditioning for Cerebral Ischemia in Patients With Takayasu Arteritis (TARIC-1) — RECRUITING · NA
• A Pilot Study in Severe Patients With Takayasu Arteritis. — RECRUITING · PHASE4
• Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research — NOT_YET_RECRUITING
• Cardiovascular Risk in Patients With Takayasu Arteritis: A Nationwide Population-Based Cohort Study — COMPLETED
• Long-Axial Field of View (LAFOV) [18F]FDG PET/CT Imaging in Large Vessel Vasculitis (LVV): Protocol Optimisation Study. — NOT_YET_RECRUITING · NA
• Monitoring Disease Activity in Patients With Takayasu Arteritis With the OMERACT Takayasu Ultrasound Score (OTUS) — NOT_YET_RECRUITING
• Upadacitinib for Refractory Takayasu Arteritis — COMPLETED
• Phase II Interventional Study Evaluating Efficacy and Safety of Secukinumab in Active Severe Takayasu Patients — NOT_YET_RECRUITING · PHASE2
• STARS - Prospective, bayesian, randomized, controlled, open-label, parallel-group, phase II interventional study evaluating efficacy and safety of secukinumab versus standard of care in active severe Takayasu patients — TERMINATED · PHASE2
• Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis — NOT_YET_RECRUITING · PHASE4
• INTOReTAK - Multicentre, randomized, prospective trial evaluating the efficacy and safety of Infliximab to tocilizumab in refractory or relapsing Takayasu arteritis - INTOReTAK : INfliximab and TOcilizumab in Refractory/relapsing TAKayasu arteritis — TERMINATED · PHASE2
• A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK) — ACTIVE_NOT_RECRUITING · PHASE3
• Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis — COMPLETED · PHASE2
• Effect of Pirfenidone on TA Fibrosis — NOT_YET_RECRUITING · PHASE4
• Surgery Benefits Takayasu Arteritis With Stenosis in the Descending Aorta — COMPLETED
• Turkish Adaptation of the VascuQoL-6 Quality of Life Scale — COMPLETED
• Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis — TERMINATED · PHASE2
• The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis — NOT_YET_RECRUITING · PHASE4
• A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK) — TERMINATED · PHASE3
• Takayasu Arteritis Clinical Trial in China — COMPLETED · NA
• Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis — ACTIVE_NOT_RECRUITING
• A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases. — NOT_YET_RECRUITING
• Baricitinib for Refractory Takayasu Arteritis — COMPLETED · PHASE2
• PET Imaging of Giant Cell and Takayasu Arteritis — OTHER
• ICF in Takayasu Arteritis — COMPLETED · NA
• Pediatric Vasculitis Initiative — OTHER
• Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis — COMPLETED · PHASE3
• Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis — OTHER · PHASE4
• Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis — OTHER · PHASE3
• Drug-coated Balloon for Takayasu Arteritis Associated Renal Artery Stenosis — OTHER · NA
• Takayasu Arteritis Activity Evaluation by Ultrafast Ultrasound Imaging — COMPLETED · NA
• The Registry Study of Takayasu Arteritis in East China — OTHER
• Aerobic Capacity and Strength Exercise in Takayasu's Arteritis — COMPLETED · NA
• Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity — COMPLETED
• Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis — OTHER · PHASE2
• Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases — COMPLETED · PHASE1
• Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis — COMPLETED · PHASE3
• Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients — OTHER · PHASE4

Refine this search